Taiwan

Interesting Medicinal Plants for Arthritis Care|

and and and and and and and and and and and and and (2011) Bioorganic & Medicinal Chemistry, Vol. 19 (23), p. 7070-7084. eISSN 1464-3391. Article.|

, , , , , , , , , , , , , , , , , , , and (2007) Journal of Medicinal Chemistry, 50 (20). pp. 4789-4792. ISSN 0022-2623 (Print), 1520-4804 (Online) (doi:)|

The expected impact of the amendment is, based on the transposition of Directive 2011/62/EC, prevention of falsified medicinal products. For this purpose, additional requirements and obligations have been introduced mainly for holders of activity licenses for manufacture and wholesale trade in medicinal products, holders of activity licences for pharmacy services, and the State Agency of Medicines.|

is a multi-disciplinary journal which publishes both highly-significant research in traditional areas of medicinal chemistry and cutting edge work in new or interdisciplinary areas. The journal's mission is to broaden the field of opportunity for medicinal chemists, bringing new thinking to the subject and challenging perceptions of what is possible in drug discovery. Research in other disciplines which has an impact or application in medicinal chemistry is particularly welcomed and encouraged.|

Position paper on the assessment of the risk of transmission of animal spongiform encephalopathy agents by master seed materials used in the production of veterinary vaccines (EMEA/CVMP/019/01 February 2001) available in all languages of the European Community. This position paper on master seed materials used in the production of veterinary vaccines should be seen and used in conjunction with joint CPMP/CVMP Note for Guidance on minimising the risk of transmitting animal spongiform encephalopathy (TSE) agents via human and veterinary medicinal products.|

A holder of a general pharmacy licence may apply for the right to sell at a distance medicinal products used in human health care and over-the-counter medicinal products used in veterinary medicine. The sale of prescription medicinal products used in veterinary medicine is restricted as there are no digital prescriptions in use for veterinary purposes.|

In accordance with Article 106 of Directive 2001/83/EC and Article 77 of Directive 2001/82/EC, of the Rules governing Medicinal products in the European Union ) on Pharmacovigilance for human and veterinary medicinal products has been published by the Commission today. This Volume has been prepared in close consultation with the European Agency for the Evaluation of Medicinal Products (the Agency), member states and interested parties. It brings together, for the first time, general guidance on the requirements, procedures, roles and activities in pharmacovigilance, for both industry and regulators of medicinal products. It also incorporates international agreements reached within the framework of the International Conference on Harmonisation (ICH) and makes specific reference to the international terminology, MedDRA. Today's publication coincides with the date on which Member States have to comply with Directives 2000/38/EC and 2000/39/EC which amended the pharmacovigilance chapters of Directives 75/319/EEC and 81/851/EEC respectively. These amendments are now integrated into the two codifying Directives on the Community Codes relating to medicinal products for veterinary and human use ( and ) referred to above (see also the news entry of 28/11/01).|

Uncle Paul he was very small, he Was the shortest man in town He rubbed his body with medicinal compound Now he weighs only half a pound.|

Early August, the deputy minister of water and environmental affairs, Rejoice Mabudafashi, opened a R20 million medicinal plant conservation project in the Maila village, Limpopo Province.|

Corrigendum to Guideline 3A-Q4A of Volume 3A of The Rules Governing Medicinal Products in the European Union It has come to our attention that page 27 of Volume 3A of The Rules Governing Medicinal Products in the European Union contains a typographical error. In section 4.2, paragraph C of The use of Ionising radiation in the manufacture of medicinal products, >107cfu/single unit should read . We apologise for any inconvenience caused by this mistake.|

Updated Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMEA/410/01 Rev.1 May 2001) available in all languages of the European Community This joint CPMP/CVMP Note for Guidance is a revised version of the respective CPMP and CVMP Notes for Guidance on minimising the risk of transmitting TSE via medicinal products. Compliance with this Note for guidance has to be demonstrated according to Council Directive 75/318/EEC as amended by Commission Directive 1999/82EC) and Council Directive 81/852/EEC as amended by Commission Directive 1999/104/EC|

Herbal medicinal products contain naturally occurring substances in concentrations that are not substantially greater than those found in nature.|